Literature DB >> 17996181

[The importance of investigating the internal thoracic artery before coronary artery surgery in Leriche's syndrome].

María C Ferrer1, Isabel Calvo, Juan Sánchez-Rubio, Gabriel Galache, José A Diarte, Antonela Lukic, Ana Portolés, Luis Placer.   

Abstract

Frequently, both peripheral and coronary artery disease are present in the same patient. In patients with abdominal aortic occlusion (i.e., Leriche's syndrome) or femoroiliac occlusion, collateral circulation to the lower extremities can originate in branches of the abdominal aorta or even in the internal thoracic artery (depending on the level of the occlusion). It is important to identify the origin of this circulation during diagnostic procedures, especially in patients who may need to undergo coronary revascularization surgery since, in cases where the majority of the collateral circulation originates in the internal thoracic artery, using the artery as a coronary graft could lead to acute ischemia of the lower extremities. We present three patients with Leriche's syndrome in whom the internal thoracic artery was the origin of the collateral circulation to the ipsilateral femoral artery.

Entities:  

Mesh:

Year:  2007        PMID: 17996181

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  2 in total

1.  Multidetector Computed Tomographic Angiography for Optimal Cartography of the Visceral Abdominal Arterial Network: An Extensive Pictorial Review with Emphasis on Common and Uncommon Collateral Pathways, Complications and some Specific Syndromes.

Authors:  Bruno Coulier
Journal:  J Belg Soc Radiol       Date:  2017-02-01       Impact factor: 1.894

2.  The use of both internal thoracic arteries for coronary revascularization increases the estimate of post-operative lower limb ischemia in patients with peripheral artery disease.

Authors:  Linda Renata Micali; Massimo Bonacchi; Daniel Weigel; Rosie Howe; Orlando Parise; Gianmarco Parise; Sandro Gelsomino
Journal:  J Cardiothorac Surg       Date:  2020-09-25       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.